Frailty in clinical drug trials: Frailty assessments, subgroup analyses and outcomes.

Br J Clin Pharmacol · 2025 · PMC11671326 · PMID 38509766

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

There may be significant challenges to conducting frailty assessments in clinical drug trials.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.